
By Christine Dobby, Postmedia News October 17, 2011 TORONTO - Valeant Pharmaceuticals International Inc. said Tuesday it has taken control of Afexa Life Sciences Inc. after acquiring almost 81 million shares under its offer to purchase the Cold-FX ... Valeant takes control of Cold-FX maker
No comments:
Post a Comment